Non-opioid pain meds for veterans
What the bill does
This bill requires the Department of Veterans Affairs to add certain non-opioid pain medications to its national formulary within a set timeframe. The medications must be FDA-approved for reducing postoperative pain or treating acute pain without acting on opioid receptors. The bill also prohibits using funds from the Cost of War Toxic Exposures Fund to pay for these changes.
The stakes
Veterans who need pain relief would have faster access to non-opioid options, which could help reduce the risk of opioid addiction. The bill affects how the VA manages its drug list and spends money.
- PfizerPFE
- Johnson & JohnsonJNJ
- Eli LillyLLY
What each side says
Each point links to its source. The views are attributed to those sources, not stated as ours.
From this bill outward
The bill
where every tie is measured fromWho paid lobbyists to work it
Direct tie3 groups · their total 2025 lobbying| Group | Issues | 2025 lobbying (all issues) | Has PAC? |
|---|---|---|---|
| PFIZER INC›Named in bill | ForeignHealthBanking | $13M | ✓PP |
| ELI LILLY AND COMPANY›Named in bill | HealthForeignBanking | $11M | ✓ELACPAC |
| JOHNSON & JOHNSON SERVICES, INC.›Named in bill | HealthBankingOther | $8.4M | ✓JJP |
Election money, in the distance
Background · not tied to this billThe background money view appears when a bill has a recorded vote and matching sector PAC data.
Lobbying filings, contributions, and votes are public records shown side by side. The further down the chain, the further the money is from this bill. This page does not assert that money caused any vote.